discovery of glp-1 The transformative breakthroughs in research recognized by the 2024 Lasker~DeBakey award | Current Medicine Frontiers | Research progress of

GLP-1 agonists have been a welcome addition to the armamentarium in the treatment of diabetes and obesity

Strip away the marketing language about pipelines and innovation platforms, and what you have is a business

It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

Despite Polycystic Ovary Syndrome (PCOS) is a very prevalent disorder among women of reproductive age, there is widespread agreement that until now, no pharmacological options are available to tackle the entire spectrum of clinical manifestations encountered in the clinical practice

semaglutide or tirzepatide), are of benefit following metabolic surgery

Rocio Salas-Whalen, an expert in obesity medicine, delivers the real-world strategies that have helped thousands of patients achieve health goals that once felt out of reach